Hottub News

Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology

2 reports from 2 outlets in 1 language · first reported · updated · JSON

HealthZealand Pharma

Reports

  1. Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & EndocrinologyPublished by manilatimes.net, GlobeNewswire — all ·

More in Health

  1. Democratic Republic of Congo: More than 4,000 people in the DR Congo have died from Ebola98 outlets
  2. Former Eljamel patient’s ‘shock’ at health board’s approach to inquiry131 outlets
  3. On ventilator and unconscious, what's next for Christa Pike after surviving lethal injection46 outlets
  4. More than 4000 Ebola deaths in Democratic Republic of Congo63 outlets
  5. Life expectancy almost back to pre-Covid levels, says WHO42 outlets
  6. Disease-carrying ticks 'living for longer' in UK43 outlets